84. サルコイドーシス Sarcoidosis Clinical trials / Disease details

臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02824419 (ClinicalTrials.gov)	May 2016	27/5/2016	Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis	Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis	Pulmonary Sarcoidosis	Drug: Methionine;Drug: DOTANOC	Turku University Hospital	NULL	Recruiting	18 Years	N/A	Both	10	Phase 2/Phase 3	Finland
2	EUCTR2015-001815-11-FI (EUCTR)	19/04/2016	29/12/2015	PET imaging of pulmonary sarcoidosis	Imaging of active granulomas with [18F]FDG and selected inflammatory PET tracers in pulmonary sarcoidosis	Pulmonary sarcoidosis with active garnulomas in the lungs. The diagnosis is based on the clinical evidence or biopsy. MedDRA version: 18.1;Level: PT;Classification code 10037430;Term: Pulmonary sarcoidosis;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]	Product Name: 18F-fluorodeoxyglucose Product Code: FDG INN or Proposed INN: FLUORINE (18F) FLUDEOXYGLUCOSE Product Name: C11-methionine INN or Proposed INN: L-methionine Other descriptive name: L-METHIONINE ([11C]METHYL) Product Name: 68Ga-DOTANOC INN or Proposed INN: DOTANOC Other descriptive name: DOTANOC	Turku PET Centre	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Finland